Surviving Sepsis Campaign 2021 Guidelines Vasoactive Agent Management - PDF
Document Details
Uploaded by DeliciousDream5791
2021
Tags
Related
- What's New in Pulmonary and Critical Care Medicine (UpToDate) PDF
- Small Animal Critical Care Medicine (Key Critical Care Concepts) PDF
- Chapter 112 - Acute Abdominal Pain PDF
- Small Animal Critical Care Medicine PDF (XIX Miscellaneous Disorders)
- Diabetic Ketoacidosis PDF
- The MINUTES Bundle for Initial 30-Minute Management of Undifferentiated Circulatory Shock (2024) - PDF
Summary
This is a clinical guideline on management strategies for septic shock related to vasoactive agent use, from the Society of Critical Care Medicine and European Society of Intensive Care Medicine. Recommendations on medication use are given. It includes criteria for when to use certain medications.
Full Transcript
Vasoactive Agent Management Use norepinephrine as first-line vasopressor....
Vasoactive Agent Management Use norepinephrine as first-line vasopressor. Target a MAP of 65 mm Hg. For patients with septic shock on vasopressors Consider invasive monitoring of arterial ! blood pressure. If central access is not Consider initiating vasopressors yet available ! peripherally.* If MAP is inadequate despite low-to-moderate norepinephrine ! Consider adding vasopressin. If cardiac dysfunction with persistent hypoperfusion is Consider adding dobutamine or switching present despite adequate volume ! to epinephrine. status and blood pressure Strong recommendations are displayed in green Weak recommendations are displayed in yellow. *When vasopressors are used peripherally, they should be administered only for a short period of time and in a vein proximal to the antecubital fossa. © 2021 Society of Critical Care Medicine and European Society of Intensive Care Medicine. The Society of Critical Care Medicine and SCCM are registered trademarks of the Society of Critical Care Medicine.
